Viewing Study NCT04666168


Ignite Creation Date: 2025-12-24 @ 5:45 PM
Ignite Modification Date: 2026-02-03 @ 5:55 AM
Study NCT ID: NCT04666168
Status: UNKNOWN
Last Update Posted: 2020-12-14
First Post: 2020-11-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Multicenter Clinical Study on the Safety and Efficacy of CAR-T in the Treatment of Relapsed / Refractory Non Hodgkin's Lymphoma
Sponsor: Hebei Senlang Biotechnology Inc., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-hodgkin's Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None NHL View